Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anirban Maitra, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Maryland, and Connecticut. He is an Assistant Professor of Pathology at Johns Hopkins University.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Pathology, 1999 - 2000- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1999
All India Institute of Medical SciencesClass of 1996
Certifications & Licensure
TX State Medical License 2014 - 2026
MD State Medical License 2001 - 2015
CT State Medical License 1999 - 2001
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing.Johannes F Fahrmann, Michele Yip-Schneider, Jody Vykoukal, Rachelle Spencer, Jennifer B Dennison
Cancer Letters. 2025-03-01 - 2 citationsTREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1βMacrophages.Daowei Yang, Xinlei Sun, Hua Wang, Ignacio I Wistuba, Huamin Wang
Gastroenterology. 2025-02-14 - Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2025-02-01
Press Mentions
Experimental Blood Test Improves Early Detection of Pancreatic CancerOctober 4th, 2024- Small Pancreatic Cancer Vaccine Trial Shows PromiseMay 16th, 2023
- Pancreatic Cancer Vaccine Shows Promising Results in Small StudyMay 11th, 2023
- Join now to see all
Grant Support
- Effects of Tissue Block Age on Reliability and Accuracy of In situ Transcriptomics Across Organ Sites using Xenium TechnologyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- Effects of Tissue Block Age on Reliability and Accuracy of In situ Transcriptomics Across Organ Sites using Xenium TechnologyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)UNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)UNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- Effects of Tissue Block Age on Reliability and Accuracy of In situ Transcriptomics Across Organ Sites using Xenium TechnologyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- Clinical Validation Center for Early Detection of Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2016–2027
- Clinical Validation Center for Early Detection of Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2016–2027
- The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
- The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
- MD Anderson Cancer Center SPORE in Gastrointestinal CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2019–2025
- Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)UNIVERSITY OF TX MD ANDERSON CAN CTR2015–2025
- Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)UNIVERSITY OF TX MD ANDERSON CAN CTR2015–2025
